Literature DB >> 16243534

Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population.

Jeane Eliete Laguila Visentainer1, Sofia Rocha Lieber, Lígia Beatriz Lopes Persoli, Sílvia Barbosa Dutra Marques, Afonso Celso Vigorito, Francisco José Penteado Aranha, Kátia Aparecida de Brito Eid, Gislaine Borba Oliveira, Eliana Cristina Martins Miranda, Luciana Bragotto, Cármino Antonio de Souza.   

Abstract

Graft-versus-host disease (GVHD) is the major complication of allogeneic hematopoietic stem cell transplantation (HSCT), and cytokines are recognized as important mediators of GVHD. Polymorphisms in the regulatory regions of several cytokine genes have been associated with a number of immune diseases as well as organ transplant complications. In this study we have investigated the role of tumor necrosis factor-alpha(-308), interleukin (IL)-6(-174), IL-10(-1082, -819, -592), Interferon-gamma(-874), and transforming growth factor-beta1(+869, +915) polymorphisms on HSCT outcome. Donor/recipient genotypes were analyzed by polymerase chain reaction with sequence specific primers (PCR-SSP). Although we have found a small number of low IL-6, a polymorphism at position -174 of the recipient and donor IL-6 gene was associated with the increased incidence of chronic GVHD. Therefore, this study emphasizes the probable potential role of genetic variability of donor and recipient in determining outcome after transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16243534     DOI: 10.1016/j.cyto.2005.09.002

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  10 in total

Review 1.  Biomarkers in chronic graft-versus-host disease.

Authors:  Jacob Rozmus; Kirk R Schultz
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

2.  Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors.

Authors:  Esteban Arrieta-Bolaños; Neema P Mayor; Steven G E Marsh; J Alejandro Madrigal; Jane F Apperley; Keiren Kirkland; Stephen Mackinnon; David I Marks; Grant McQuaker; Julia Perry; Michael N Potter; Nigel H Russell; Kirsty Thomson; Bronwen E Shaw
Journal:  Haematologica       Date:  2015-11-26       Impact factor: 9.941

Review 3.  Biologic markers of chronic GVHD.

Authors:  J Pidala; M Sarwal; S Roedder; S J Lee
Journal:  Bone Marrow Transplant       Date:  2013-07-22       Impact factor: 5.483

4.  Cytokine gene polymorphism and graft-versus-host disease: a survey in Iranian bone marrow transplanted patients.

Authors:  Mohammad Reza Noori-Daloii; Nazanin Jalilian; Pantea Izadi; Maryam Sobhani; Zeinab Rabii-Gilani; Mir Saeed Yekaninejad
Journal:  Mol Biol Rep       Date:  2013-05-06       Impact factor: 2.316

5.  Distribution of cytokine gene single nucleotide polymorphisms among a multi-ethnic Iranian population.

Authors:  Zana Karimi Kurdistani; Samaneh Saberi; Yeganeh Talebkhan; Akbar Oghalaie; Maryam Esmaeili; Nazanin Mohajerani; Maryam Bababeik; Parisa Hassanpour; Shaghik Barani; Ameneh Farjaddoost; Fatemeh Ebrahimzadeh; Jean Trejaut; Marjan Mohammadi
Journal:  Adv Biomed Res       Date:  2015-07-31

Review 6.  Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target.

Authors:  Tor Henrik Anderson Tvedt; Elisabeth Ersvaer; Anders Aune Tveita; Øystein Bruserud
Journal:  Front Immunol       Date:  2017-06-08       Impact factor: 7.561

7.  Investigation of TGFB1 -1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation.

Authors:  Petra Kövy; Nóra Meggyesi; Lívia Varga; Katalin Balassa; András Bors; László Gopcsa; Melinda Paksi; Árpád Bátai; Eszter Vad; János Sinkó; Attila Tordai; Tamás Masszi; Péter Reményi; Hajnalka Andrikovics
Journal:  Bone Marrow Transplant       Date:  2019-09-16       Impact factor: 5.483

8.  Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation.

Authors:  Danilo Santana Alessio Franceschi; Cármino Antonio de Souza; Francisco José Penteado Aranha; Daniela Maira Cardozo; Ana Maria Sell; Jeane Eliete Laguila Visentainer
Journal:  Rev Bras Hematol Hemoter       Date:  2011

9.  Transforming growth factor-β1 polymorphisms and graft-versus-host disease risk: a meta-analysis.

Authors:  Lin Zhang; Lihong Mao; Junxiu Xu
Journal:  Oncotarget       Date:  2016-01-19

10.  Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.

Authors:  Jukka Partanen; Kati Hyvärinen; Heike Bickeböller; Katarzyna Bogunia-Kubik; Rachel E Crossland; Milena Ivanova; Francesca Perutelli; Ralf Dressel
Journal:  Front Immunol       Date:  2020-10-19       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.